Avenue Therapeutics, Inc. (ATXI)
OTCMKTS · Delayed Price · Currency is USD
0.4300
+0.0100 (2.38%)
At close: Oct 14, 2026
Avenue Therapeutics Employees
Avenue Therapeutics had 1 employees as of December 31, 2025. The number of employees decreased by 1 or -50.00% compared to the previous year. That makes Avenue Therapeutics the 43,981st largest employer in the world and 7,302nd in the United States.
Employees
1
Change (1Y)
-1
Growth (1Y)
-50.00%
Revenue / Employee
n/a
Profits / Employee
-$2,777,000
Market Cap
1.42M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 1 | -1 | -50.00% |
| Dec 31, 2024 | 2 | -1 | -33.33% |
| Dec 31, 2023 | 3 | 1 | 50.00% |
| Dec 31, 2022 | 2 | -2 | -50.00% |
| Dec 31, 2021 | 4 | 0 | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| CASI Pharmaceuticals | 214 |
| BioAtla | 41 |
| International Stem Cell | 33 |
| Evofem Biosciences | 29 |
| NKGen Biotech | 26 |
| Aditxt | 26 |
| AXIM Biotechnologies | 7 |
| AccuStem Sciences | 4 |
Avenue Therapeutics News
- 2 months ago - Avenue Therapeutics Quarterly report: Q2 2026 - Filings
- 5 months ago - Avenue Therapeutics Quarterly report: Q1 2026 - Filings
- 6 months ago - Avenue Therapeutics Annual report: Q4 2025 - Filings
- 7 months ago - Avenue Therapeutics enters worldwide license agreement for ATX-04 - TheFly
- 9 months ago - Avenue Therapeutics Transcript: AGM 2025 - Transcripts
- 10 months ago - Avenue Therapeutics Proxy statement: Proxy Filing - Filings
- 11 months ago - Avenue Therapeutics Quarterly report: Q3 2025 - Filings
- 11 months ago - Avenue Therapeutics announces Baergic Bio acquisition by Axsome - TheFly